Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market is expected to grow with an estimated CAGR of 5% over the forecast period 2022-2028.

Nonsteroidal anti-inflammatory drugs are used to prevent pain, high fever, and blood clots. Inflammation is also reduced when high doses of nonsteroidal anti-inflammatory drugs (NSAIDs) are given. Nonsteroidal drugs with depressive and anti-inflammatory properties. Nonsteroidal anti-inflammatory drugs (NSAIDs) work by inhibiting the enzymes COX-1 and COX-2 that cause inflammation. Paracetamol, ibuprofen, aspirin, and naproxen are common types of nonsteroidal anti-inflammatory drugs.

Market Segments

By Disease Indication

• Arthritis
• Migraine
• Ophthalmic Diseases

By Route of Administration

• Oral
• Parenteral

Key Players

• Pfizer Inc.
• GlaxoSmithKline plc
• Boehringer Ingelheim International GmbH
• Johnson & Johnson Services, Inc.
• Bayer AG
• AstraZeneca
• Zyla Life Sciences
• Horizon Therapeutics plc

Scope of the Report

The research study analyzes the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Report

1. What was the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.